Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Naltrexone

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Naltrexone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 6,942Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Oar Health Introduces Clutch Mint For Alcohol Use Disorder
    Oar Health Introduces Clutch Mint For Alcohol Use Disorder

    12 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251112850345/en/Oar-Health-Launches-Clutch-the-First-Ever-Fast-Acting-Mint-to-Treat-Alcohol-Use-Disorder

    BUSINESSWIRE
    12 Nov 2025
    Share Share
    Currax Shows CONTRAVE Data at ObesityWeek on Cravings Control
    Currax Shows CONTRAVE Data at ObesityWeek on Cravings Control

    04 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/currax-announces-obesityweek-data-showing-that-contrave-helps-curb-cravings-and-offers-marked-effectiveness-in-certain-populations-with-obesity-302604348.html

    PR NEWSWIRE
    04 Nov 2025
    Share Share
    Currax Pharma Showcases CONTRAVE Research At Obesityweek 2025
    Currax Pharma Showcases CONTRAVE Research At Obesityweek 2025

    28 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/currax-pharmaceuticals-to-spotlight-new-research-at-obesityweek-2025-highlighting-craving-control-behavioral-adherence-and-subpopulation-outcomes-with-contrave-302596289.html

    PR NEWSWIRE
    28 Oct 2025
    Share Share
    Currax to Offer CONTRAVE Free to Federal Staff During Shutdown
    Currax to Offer CONTRAVE Free to Federal Staff During Shutdown

    23 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/currax-pharmaceuticals-llc-to-provide-contrave-at-no-cost-to-federal-employees-during-government-shutdown-302592592.html

    PR NEWSWIRE
    23 Oct 2025
    Share Share
    Alkermes Faces Lawsuit For Blocking Generic Vivitrol
    Alkermes Faces Lawsuit For Blocking Generic Vivitrol

    03 Oct 2025

    // REUTERS

    https://www.reuters.com/legal/government/alkermes-sued-over-alleged-scheme-block-generic-vivitrol-2025-10-03/

    REUTERS
    03 Oct 2025
    Share Share
    Currax Study In Obesity Pillars Supports CONTRAVE/MYSIMBA CV Safety
    Currax Study In Obesity Pillars Supports CONTRAVE/MYSIMBA CV Safety

    11 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/currax-pharmaceuticals-peer-reviewed-study-in-obesity-pillars-further-substantiates-cardiovascular-safety-profile-of-contravemysimba-302397897.html

    PR NEWSWIRE
    11 Mar 2025
    Share Share